{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:50:15Z","timestamp":1789548615307,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.clinthera.2010.09.009","type":"journal-article","created":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T04:15:21Z","timestamp":1293596121000},"page":"1749-1751","source":"Crossref","is-referenced-by-count":35,"title":["Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists"],"prefix":"10.1016","volume":"32","author":[{"given":"Bradley S.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem R.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.09.009_bib1","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.clinthera.2010.09.009_bib2","series-title":"Lupron Depot Ped (leuprolide acetate for depot suspension) [package insert]","year":"2008"},{"key":"10.1016\/j.clinthera.2010.09.009_bib3","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1210\/jc.2001-020243","article-title":"Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg)","volume":"87","author":"Carel","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.clinthera.2010.09.009_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0022-3476(05)81720-2","article-title":"Local reactions to depot leuprolide therapy for central precocious puberty","volume":"123","author":"Manasco","year":"1993","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2010.09.009_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(05)81162-X","article-title":"Two-year results of treatment with depot leuprolide acetate for central precocious puberty","volume":"121","author":"Neely","year":"1992","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2010.09.009_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3476(95)70534-1","article-title":"Local reactions to luteinizing hormone releasing hormone analog therapy","volume":"126","author":"Tonini","year":"1995","journal-title":"J Pediatr."},{"key":"10.1016\/j.clinthera.2010.09.009_bib7","series-title":"(histrelin implant) [package insert]","author":"Supprelin","year":"2009"},{"key":"10.1016\/j.clinthera.2010.09.009_bib8","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2006-2479","article-title":"Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: A multicenter trial","volume":"92","author":"Eugster","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.clinthera.2010.09.009_bib9","doi-asserted-by":"crossref","first-page":"812517","DOI":"10.1155\/2009\/812517","article-title":"Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty","volume":"2009","author":"Rahhal","year":"2009","journal-title":"Int J Pediatr Endocrinol."},{"key":"10.1016\/j.clinthera.2010.09.009_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.09.009_bib11_1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2005.11.015","article-title":"Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms?","volume":"67","author":"Daskivich","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2010.09.009_bib11_2","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.urology.2005.11.015","article-title":"Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: Insight into mechanisms?","volume":"67","author":"Daskivich","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2010.09.009_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-5347(05)64864-1","article-title":"Resistance to luteinizing hormone releasing hormone agonist therapy for metastatic prostate cancer","volume":"168","author":"Curry","year":"2002","journal-title":"J Urol."},{"key":"10.1016\/j.clinthera.2010.09.009_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0022-5347(05)00649-X","article-title":"Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer","volume":"175","author":"Schlegel","year":"2006","journal-title":"J Urol."},{"key":"10.1016\/j.clinthera.2010.09.009_bib15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-4295(01)01293-6","article-title":"Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin","volume":"58","author":"Schlegel","year":"2001","journal-title":"Urology."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T06:43:15Z","timestamp":1559889795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810003188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0149291810003188"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.09.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}